Average hydrodynamic diameter (<d>) was 8.9 nm at 40 °C. The concentration of FPT was 0.001 w/v%.
∆Temperature was calculated by subtracting the average temperature of the cytoplasm from that of the centrosome with the potential maximum error of 0.25 °C. <∆T> represents an average of the histogram. The medium temperature was maintained at 30 °C. Bar, 10 µm. 
Supplementary Methods
Fluorescence measurements with a spectrofluorometer. Fluorescence spectra were obtained using an FP-6500 spectrofluorometer (JASCO) with an optional R-7029 photomultiplier tube (Hamamatsu, operative range: 200-850 nm). The temperature was controlled by an ETC-273T controller (JASCO) and monitored with a platinum resistance thermometer. The samples (0.001 w/v%) were equilibrated at each temperature for at least 1 min. Bovine serum albumin (BSA, Sigma) was used in the solution to study the effect of co-existing proteins. The fluorescence quantum yield was determined with 4-methylamino-7-nitro-2,1,3-benzoxadiazole (0.38 in acetonitrile with excitation at 458 nm 47 ) as a reference.
Cell culture. COS7 cells (African green monkey SV40-transformed kidney fibroblast cell line) and HeLa cells (human epithelial carcinoma cell line) were cultured on a 35 mm glass base dish (No. 3910-035, ASAHI Techno GLASS) in Dulbecco's Modified Eagle Medium (DMEM, Gibco No. 11965) , supplemented with 5% fetal bovine serum (Gibco), penicillin-streptomycin (Gibco), L-glutamine (Gibco), sodium pyruvate (Gibco) and non-essential amino acids (Gibco). Before live cell imaging, the medium was replaced by phenol red-free culture medium (2 mL, Gibco No. 21063 was used instead of No. 11965 in the above recipe). Cell cycles were synchronized to G1 and S/G2 phases using thymidine (Sigma)-nocodazole (Sigma) and thymidine, respectively 48 .
Temperature imaging of living HeLa cells. The procedures for temperature imaging of COS7 cells were also used for HeLa cells. The calibration curve for the temperature imaging of HeLa cells was τ f (T) = 1.841 × 10 −6 T 6 − 5.257 × 10 −4 T 5 + 5.789 × 10 −2 T 4 − 3.236 T 3 + 9.822 × 10 1 T 2 − 1.548 × 10 3 T + 9.946 × 10 3 (S1) Study on the effects of environmental viscosity on the fluorescence response of FPT. The mobility of FPT in living cells was investigated by fluorescence recovery after photobleaching (FRAP). In the FRAP experiments 49 , a small round area in living COS7 cells microinjected with FPT was photobleached for 10 seconds with the sapphire laser light (Model 488-30 CDRH, Coherent) focused onto the area either in the cytoplasm or in the nucleus, followed by time-lapse epi-fluoresccence imaging (described in Methods) over 5 minutes (in the cytoplasm) or 10 minutes (in the nucleus) with a Q505LP dichroic mirror (Chroma technology) and a HQ535/50X emission filter (Chroma technology). In the image analysis, the fluorescence recovery was determined using the ratio of the averaged fluorescence intensity of the photobleached spot area to that of the whole cytoplasm or the whole nucleus calculated for each time point after the subtraction of the averaged background intensity. The time course of fluorescence recovery (F(t)) was fitted by a single exponential function using KaleidaGraph 3.6 (Synergy Software):
The effects of environmental viscosity on the fluorescence lifetime of FPT were studied using Ficoll solutions with various concentrations. In the fluorescence lifetime measurements, FPT (0.002 w/v%) and Ficoll (0-35 mg/mL, Sigma) were dissolved in 150 mM KCl solution. The fluorescence lifetime of the solution was measured using a FluoroCube 3000U with an ETC-273T temperature controller. The samples were excited with a light emitting diode (NanoLED-460, Horiba, 456 nm) at a repetition rate of 1 MHz, and emissions from 574 to 576 nm were collected. The viscosity of the solution was measured using a torsional oscillation viscometer VM-10A-L (Sekonic). Biol. Cell 13, 1977 -2000 (2002 . 49. Meyvis, T. K. L., De Smedt, S. C., Oostveldt, P. V. & Demeester J. Fluorescence recovery after photobleaching: a versatile tool for mobility and interaction measurements in pharmaceutical research. Pharm. Res. 16, 1153 Res. 16, -1162 Res. 16, (1999 .
Supplementary

